{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:18:06Z","timestamp":1790680686181,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.autrev.2017.11.020","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T09:32:52Z","timestamp":1512207172000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature"],"prefix":"10.1016","volume":"17","author":[{"given":"Dilia","family":"Giuggioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lumetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Colaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clodoveo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.11.020_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.11.020_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","article-title":"The many faces of scleroderma","volume":"34","author":"Steen","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2017.11.020_bb0015","first-page":"30933","article-title":"Systemic sclerosis","volume":"S0140-6736","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.11.020_bb0020","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl 76","key":"10.1016\/j.autrev.2017.11.020_bb0025","first-page":"71","article-title":"Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry","volume":"31","author":"Guillevin","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2017.11.020_bb0030","first-page":"19","article-title":"Digital ulcers: overt vascular disease in systemic sclerosis","volume":"48","author":"Steen","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0040","first-page":"5","article-title":"Procedural pain management in the treatment of scleroderma digital ulcers","volume":"33","author":"Giuggioli","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.11.020_bb0050","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.24333","article-title":"Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis","volume":"60","author":"Herrick","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","article-title":"Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma","volume":"29","author":"Hummers","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2017.11.020_bb0060","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients withsystemic sclerosis: a scleroderma clinical trials consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5301\/jsrd.5000236","article-title":"Defining skin ulcers in systemic sclerosis: systematic literature review and proposed World Scleroderma Foundation (WSF) definition","volume":"2","author":"Suliman","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.autrev.2017.11.020_bb0075","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/rheumatology\/kew313","article-title":"Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study","volume":"55","author":"Baron","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0080","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0085","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.11.020_bb0090","series-title":"Braun-Falco's dermatology","year":"2009"},{"key":"10.1016\/j.autrev.2017.11.020_bb0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","article-title":"Osteomyelitis complicating scleroderma digital ulcers","volume":"32","author":"Giuggioli","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0100","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.11.020_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3899\/jrheum.150382","article-title":"Therapeutic practice in more than 3000 patients","volume":"43","author":"Moinzadeh","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.11.020_bb0115","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.11.020_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.semarthrit.2016.12.003","article-title":"Evidence-based management of systemic sclerosis: navigating recommendations and guidelines","volume":"6","author":"Pellar","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0125","first-page":"26","article-title":"The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients","volume":"58","author":"Giuggioli","year":"2006","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2017.11.020_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2230.2010.03847.x","article-title":"Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers","volume":"35","author":"Ferri","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1524-475X.11.s2.1.x","article-title":"Wound bed preparation: a systematic approach to wound management","volume":"11","author":"Schultz","year":"2003","journal-title":"Wound Repair Regen"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2017.11.020_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-481X.2012.01097.x","article-title":"Extending the TIME concept: what have we learned in the past 10years?","volume":"9","author":"Leaper","year":"2012","journal-title":"Int Wound J"},{"key":"10.1016\/j.autrev.2017.11.020_bb0145","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1002\/jps.24610","article-title":"Advanced therapeutic dressings for effective wound healing\u2013a review","volume":"104","author":"Boateng","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.autrev.2017.11.020_bb0150","series-title":"Advances in wound care: the triangle of wound assessment wounds international. florence congress. Position document","author":"World Union of Wound Healing Societies (WUWHS)","year":"2016"},{"key":"10.1016\/j.autrev.2017.11.020_bb0155","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00296-011-2038-0","article-title":"Platelet gel in the treatment of severe scleroderma skin ulcers","volume":"32","author":"Giuggioli","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.11.020_bb0160","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/keg106","article-title":"Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report","volume":"42","author":"Giuggioli","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0165","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/iwj.12424","article-title":"Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients","volume":"13","author":"Barsotti","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.autrev.2017.11.020_bb0170","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3727\/096368914X685636","article-title":"Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis","volume":"24","author":"Del Papa","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.autrev.2017.11.020_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.retram.2016.10.006","article-title":"Long-term follow-up after autologous adipose derived stromal vascular fraction injection into fingers in systemic sclerosis patients","volume":"65","author":"Daumas","year":"2017","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.autrev.2017.11.020_bb0180","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1526-4637.2010.00849.x","article-title":"Oxycodone in the long-term treatment of chronic pain related to scleroderma skin ulcers","volume":"11","author":"Giuggioli","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.autrev.2017.11.020_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0000000000000332","article-title":"Recent advances in the pathogenesis and management of Raynaud's phenomenon and digital ulcers","volume":"28","author":"Herrick","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0190","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/acr.22595","article-title":"Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review","volume":"67","author":"Willems","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.11.020_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2005.08.004","article-title":"Digital ulcers in patients with systemic sclerosis","volume":"5","author":"Chung","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.11.020_bb0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.2007.072686","article-title":"Clinical burden of digital vasculopathy in limited and diffuse systemic sclerosis","volume":"67","author":"Nihtyanova","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.11.020_bb0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2008.09004.x","article-title":"Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors","volume":"160","author":"Sunderk\u00f6tter","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaad.2008.11.025","article-title":"Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing","volume":"60","author":"Alivernini","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: resultsfrom the Canadian Scleroderma Research Group registry","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.11.020_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.11.020_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10067-013-2460-7","article-title":"Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis","volume":"33","author":"Baron","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.12968\/jowc.2014.23.10.510","article-title":"Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review","volume":"23","author":"Moran","year":"2014","journal-title":"J Wound Care"},{"key":"10.1016\/j.autrev.2017.11.020_bb0235","first-page":"939","article-title":"Optimal management of digital ulcers in systemic sclerosis","volume":"11","author":"Abraham","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2017.11.020_bb0240","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.11.020_bb0245","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","article-title":"Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials","volume":"315","author":"Khanna","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2017.11.020_bb0250","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bjd.14367","article-title":"The predict study: low risk for digital ulcer development in patients with systemicsclerosis with increasing disease duration and lack of topoisomerase-1antibodies","volume":"174","author":"Hunzelmann","year":"2016","journal-title":"Br J Dermatol"},{"issue":"Suppl. 100","key":"10.1016\/j.autrev.2017.11.020_bb0255","first-page":"142","article-title":"Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis","volume":"34","author":"Ahrens","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2016.04.004","article-title":"Systemic sclerosis: the need for structured care","volume":"30","author":"Morrisroe","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0265","first-page":"1","article-title":"Geographic variation as a risk factor for digital ulcers in systemic sclerosis patients: a multicentre registry","volume":"20","author":"Souza","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0270","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0275","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2016.05.001","article-title":"Differential diagnosis of critical digital ischemia in systemic sclerosis: report of five cases and review of the literature","volume":"46","author":"Sharp","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0280","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/40.4.410","article-title":"Foot problems in patients with systemic sclerosis","volume":"40","author":"Sari-Kouzel","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0285","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3899\/jrheum.150035","article-title":"Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: a challenge for the rheumatologist","volume":"43","author":"Blagojevic","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.11.020_bb0290","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.semarthrit.2016.04.007","article-title":"Digital ulcers and cutaneous subsets of systemic sclerosis: clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry","volume":"46","author":"Tolosa-Vilella","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.11.020_bb0295","article-title":"Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group","author":"Jaeger","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.11.020_bb0300","first-page":"161","article-title":"Plasma-exchange in the treatment of systemic rheumatic diseases: past and present experience","volume":"61","author":"Cozzi","year":"2009","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2017.11.020_bb0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/phpp.12331","article-title":"Phototherapy in systemic sclerosis: review","volume":"33","author":"Chaowattanapanit","year":"2017","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T13:36:17Z","timestamp":1535204177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217302938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1568997217302938"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.11.020","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}